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Abstract
We describe the computational design of a single-chain four-helix bundle that noncovalently self-
assembles with fully synthetic non-natural porphyrin cofactors. With this strategy, both the electronic
structure of the cofactor as well as its protein environment may be varied to explore and modulate
the functional and photophysical properties of the assembly. Solution characterization (NMR, UV/
vis) of the protein showed that it bound with high specificity to the desired cofactors, suggesting that
a uniquely structured protein and well-defined site had indeed been created. This provides a
genetically expressed single-chain protein scaffold that will allow highly facile, flexible, and
asymmetric variations to enable selective incorporation of different cofactors, surface-
immobilization and introduction of spectroscopic probes.
Introduction
The design of optically and electronically responsive molecular assemblies capable of diverse
photophysical processes is becoming increasingly feasible due to progress in the study of
electron transfer and charge separation in both biological systems and synthetic small
molecules.1–4 Recently, studies aimed at combining the strengths of these two types of systems
have been initiated through the computational design of four-helix bundles that noncovalently
self-assemble with fully synthetic non-natural porphyrin cofactors. With this strategy, both the
electronic structure of the cofactor as well as its protein environment may be varied to explore
and modulate the functional and photophysical properties of the assembly. These systems are
unlike previous de novo “maquettes” 3,5 in that these peptides were computationally designed
to recognize a unique porphyrin cofactor. Thus, while maquettes bind a large number of
porphyrins with low specificity, the computationally designed protein should have much higher
specificity. Indeed, they bound with high specificity to their desired cofactors, suggesting that
a uniquely structured protein and well-defined site had successfully been created. The initial
assemblies had D2 symmetry (PATET, Figure 1b),6–8 comprising four identical helices that
encapsulate two iron diphenylporphyrin molecules (FeDPP(III), Figure 1a).
Porphyrin-binding peptides have been extensively studied for the past 15 years, utilizing helix-
loop-helix designs with disulfide bonds, and template-assisted design strategies.1–4,9–16 Until
now, however, there have been no genetically expressed single-chain proteins that allow highly
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facile, flexible, and asymmetric variations of the protein to allow selective incorporation of
different cofactors, surface-immobilization and introduction of spectroscopic probes.
Additionally, a single-chain variant would allow for the modification of Cys residues, semi
synthesis,17 or genetic strategies for introducing unique cofactors and probes.18 To this end,
we present a single-chain version, PASC, of the originally designed four-chain helical bundle
(Figure 1c).
Despite the fact that many porphyrin-binding helical bundles have been designed and
extensively characterized, there have been significant problems associated with the
determination of their three-dimensional structures, in part because many have
conformationally fluctuating interiors.19,20 Over the years, this problem has been alleviated
somewhat through the synthesis of variants of the original “maquettes”, resulting in better
dispersion in the NMR spectra of the complexes.21 Smaller peptide-porphyrin complexes with
two helices per complex have also been structurally characterized.21–23 The availability of a
single-chain protein, such as PASC, would greatly expedite structural determination due to the
ease of incorporation of isotopic labels for heteronuclear NMR studies.
Methods
Design of PASC
Requirements for efficient cofactor binding dictated the precise protein backbone geometry.
A single low-energy structure was computed with a Monte Carlo simulated annealing protocol
that considered the following constraints: (i) a metal-metal distance between 17 and 19 Å, (ii)
optimal His N(ε) to Fe bonding interactions, (iii) second-shell hydrogen bonds between His N
(δ) and Thr O(γ), (iv) minimal steric clashes, and (v) maintenance of D2 symmetry. This process
led to imidazole rings in near-perpendicular alignment as a result of the second-shell hydrogen
bonds. These steps to obtain protein backbone and cofactor coordinates were repeated from
Cochran et al.8 and led to the same tetrameric four-helix bundle, which was then modified.
All four 32-residue helices of the original PATET bundle were shortened by four residues at
each end, except for the N-terminus of one helix, which would eventually provide the N-
terminus of the entire single-chain four-helix bundle. The helices were shortened so as to obtain
a compact (108-residue) single-chain peptide, PASC.
With regard to stabilizing the bundle, the loops take the place of hydrophobic interactions at
each end of the bundle in the previous tetrameric complex.8 The resulting bundle structure
contained three shortened 24-residue helices and one 28-residue helix. The helices were
connected through loops of natural protein structures taken from a protein database with
reduced redundancy, PDB Select.24 A program called STITCH was developed in order to
identify loops that would be most suitable to connect a given pair of unconnected helices.
STITCH enumerates helix-loop-helix superpositions and rank-orders these superpositions
according to root mean square differences (RMSD) between Cα atoms of the helical residues
that terminate the loops and the Cα atoms of the helices. Loop structures were selected having
overlaps of at least five Cα positions at each loop-helix transition. Overlapping backbone
fragments were deleted. Connection points were identified by visual inspection, looking for
closest overlap of loop and helix backbone atoms. Residues near the connection points were
relaxed using CHARMM25 steepest decent optimization for 25 steps. Bond lengths and bond
angles of the resulting backbone structure were checked using PROCHECK.26
Protein Design Steps
The identities of the four Fe-coordinating His residues and the four Thr residues to which these
are hydrogen bonded were held fixed to support the six-point coordination of the Fe(III) cations:
T12, H23, T38, H49, T65, H76, T91, H102. The identities of the remaining 100 out of 108
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positions were determined by recursive calculations using the computational design algorithm
SCADS.27,28 SCADS (which provides site-dependent amino acid probabilities) has been used
previously in a number of successful protein design studies.8,24–29 All amino acid identities
were allowed, except for cysteine and histidine to eliminate the possibility of oxidative
degradation and unwanted disulfide bridges, and to avoid cofactor coordination at sites other
than those in the positions designated above. After the first round of SCADS calculations,
identities in 24 positions were fixed because they were the most probable amino acids with
high probabilities of at least p>0.5, and frequently p>0.8: A9, A13, A16, M20, A26, K34, A35,
A39, F42, A45, M46, K50, A66, F69, A72, M73, A79, K87, A88, A92, A95, A98, and M99.
Of these, A16, M20, F42, M46, F69, M73, A95, and M99 form a complementary, asymmetric
hydrophobic core between the two porphyrin macrocycles. Note that this nonsymmetrical
packing illustrates a major advantage of a single-chain design as opposed to a tetramer because,
as symmetry is not required, more complementary packing options become available. The
hydrophobic core is shown in Figure 4.
In addition to these fixed residues, for the second-round of SCADS calculation nine interior
positions 6, 27, 36, 53, 58, 62, 80, 89, and 106, each facing one of the cofactors, were limited
to non-charged or hydrophobic amino acid identities. After this second round of SCADS
calculations, decisions about the remaining 76 amino acid identities were made based on the
resulting SCADS probability profiles in conjunction with other considerations relevant to the
design. Residues M6, Q11, Q18, R24, Q25, Q37, K40, Q44, Q51, Y52, I58, E60, V62, K64,
Q71, R77, Q78, Q90, K93, Q100, S103, Q104, and L106 were chosen because their SCADS
probabilities were the highest at their respective sites. That is, in a total of 55 out of 108 amino
acid identities were fixed based on either the requirement for the hexacoordinated Fe(III) ions
or on the highest SCADS probabilities. N-terminal residues S1, P2, E3, E4, and the final G108
form known helix capping motifs. Residues A5, Q7, E8, Q10, E15, Q21, K22, Q33, E41, Q47,
K48, Q63, Q74, K75, Q86, E94, Q96, Q97, K101, and A105 were chosen because they were
probable and because they also occupied the same positions relative to the cofactors in the
earlier successful four-helix bundle design.8 In particular, interhelical salt bridges E15-K48,
K22-E41, K75-E94 were also introduced to stabilize the fold. Positively charged R14, R67,
and R107 (together with K50 from the first round of SCADS calculations) were chosen near
the negatively charged carboxylate groups of the cofactors. D28, K29, G30, D31, D81, K82,
G83, and D84 were identified based on a statistical analysis of alpha-helical hairpin turns by
Lahr et al,.30,31 in which the authors analyzed the relative frequencies of amino acids in such
hairpin turns and found that some amino acids are preferred. Similarly, in the larger loop,
identities of the wild type residues at positions P55, A57, S59, and S61, taken from 1T06.pdb,
were kept. Q32, Q43, Q56, and Q85 were chosen over more probable charged amino acids to
reduce the overall number of charged amino acids in the protein. L36, M53, and L89 are
hydrophobic residues in interior positions facing the cofactors, which were preferred over more
probable polar amino acids. Conversely, N54 and Y68 are polar residues facing the protein
exterior, which were selected over slightly more probable hydrophobic residues. Charged
residues E17 and E70 were introduced to exploit potentially favorable intrahelical i, i+3
interactions with R14 and R67, respectively. Finally, Y27 and Y80 were chosen over the more
probable W due to their more hydrophilic character at these partially exposed sites.
PASC/FeDPP(III) Complex Preparation
The synthetic gene for PASC was obtained and the codon sequence optimized using software
from DNA2.0. The sequence was transformed into the pET28a vector from the NcoI to BamHI
restriction sites (Novagen), which contains the IPTG-inducible T7 promoter. The protein was
over-expressed in E.coli, harvested by centrifugation, and the cells lysed by sonication. The
supernatant was heat denatured for 30 minutes at 70 °C, centrifuged, and the supernatant
purified to homogeneity by reverse-phase HPLC on a preparative C4 column (Vydac). The
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molecular weight was confirmed by MALDI mass spectrometry. The lyophilized protein was
reconstituted in 50 mM phosphate, 100 mM NaCl at pH 7.5. As previously described, the
chemically synthesized FeDPP(III) cofactor was added from a stock solution in DMSO.8
Aggregation caused by this addition was minimized by briefly heating the complex to 70 °C
for 15 minutes (above the Tm of the holo-protein). After heating, the samples were equilibrated
at room temperature for an hour, and filtered though 0.22 µm PVDF membrane centrifuge filter
(Millipore) at 13,200 rpm in an Eppendorf 5415D microcentrifuge.
UV-visible and CD Spectroscopy
To verify binding of the cofactor, complex formation was monitored at the Soret band at 410
nm. UV-visible data of the complex (as prepared above) was obtained on a Cary 300 Bio UV-
Visible spectrophotometer at room temperature in a 1 cm quartz cuvette. To evaluate the
backbone and stability of the protein and the complex, CD spectroscopy was carried out at 25
°C on a Jasco 810 Spectropolarimeter in 0.1 cm cuvettes. Buffer conditions for CD experiments
were 10 mM phosphate buffer, pH 7.5, and the protein concentration was 25 to 50 µM. For
thermal denaturation experiments, the ellipticity at 222 nm was monitored as a function of
temperature. Data were collected every 2 °C with a heating rate of 1°C/min followed by a 4
minute equilibration time. Melting temperature mid-points (Tm’s) were estimated by plotting
temperature (x-axis) versus Ffold (y-axis) in which the fraction folded was estimated from the
observed ellipticity versus that for the folded and unfolded baselines. The apo-states of the
proteins were too unstable to resolve a folded baseline, so the parameters for the holo-protein
were used to approximate these values:
Determination of Aggregation State
Size Exclusion Chromatography—Gel filtration profiles were obtained using a Superdex
75 10/300GL column on an FPLC system (GE Healthcare AKTA FPLC System). To evaluate
the oligomeric state, 100 µL of the complex was injected onto the column and eluted with a
flow rate of 0.5mL/min with a mobile phase of 50 mM phosphate buffer and 100 mM NaCl,
pH 7.5. The monomeric species eluted at 12.3 mL, yielding an apparent molecular weight of
18,500 D. MWapp was calculated from a standard curve done with mass standards blue dextran,
Vo, aprotinin, 6,500 D, cytochrome C, 12,400 D, carbonic anhydrase, 29,000 D, and albumin,
66,000 D.
Analytical Ultracentrifugation—For analytical ultracentrifugation, a 300 µL sample of
150 µM PASC with 300 µM FeDPP(III) in 50 mM phosphate buffer, 100 mM NaCl at pH 7.5
was prepared as previously mentioned. After centrifuging for 10 minutes at 13,200 rpm in an
Eppendorf 5415D microcentrifuge to remove insoluble material, an aliquot of 110 µL was used
for sedimentation equilibrium experiments. These were performed at 25 °C using a Beckman
XL-I analytical ultracentrifuge. The absorbance was monitored at 280 nm, and the sample was
centrifuged at 25,000, 35,000, and 45,000 rpm (supplementary information, Figure S1). The
data were analyzed using a modified global fitting routine in IGOR Pro (Wavemetric, Inc.).
The data were well described by assuming a single molecular weight species. The protein
maintains its calculated partial specific volume when the monomeric molecular weight is held
constant. The partial specific volume of 0.7137 was calculated using SEDNTERP.23
Stoichiometry—Binding stoichiometry was determined using the monomeric species
isolated through size exclusion chromatography (SEC). The monomeric PASC/FeDPP(III)
complex was monitored for formation by UV-vis spectroscopy at 410 nm. By holding the
protein concentration fixed, various cofactor concentrations were evaluated using UV-visible
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spectroscopy to monitor the formation of the Soret band at 410 nm. The stoichiometry of the
SEC fractions were determined by a hemochrome assay32 for FeDPP(III) concentration, and
an HPLC assay for protein concentration (Figure S2). Binding stoichiometry was determined
to be 2:1, as there was no significant increase in absorbance at 410 nm with excess cofactor
(Figure S3).
NMR Analysis
Multiple preparations of 100 µM 15N-labelled PASC with 200 µM FeDPP(III) were incubated
at 70 °C for 15 minutes, allowed to equilibrate at room temperature, filtered through a 0.45 µm
Nylon syringe filter, and 2 mL injected over a preparative Superdex 75 XK16/70 column (GE
Healthcare AKTA FPLC system). The monomeric fractions were collected and concentrated
using an Amicon Ultra-15 MWCO 10,000 filter (Millipore). The sample was buffer-exchanged
into 50 mM phosphate buffer, 200 mM NaCl, pH 7.5 over a PD-10 column (GE Healthcare)
and concentrated to 270 µL for the NMR experiment. The final sample was diluted to 300 µL
with D20, and 2 µL of 150 mM 3-(Trimethylsilyl)-1-propanesulfonic acid sodium salt stock
(Fluka) in water was added. The final concentrations of cofactor and protein were determined
by hemochrome and HPLC assays (Figure S2).
The 1H-15N HSQC spectrum was recorded at 45 °C on a Bruker DMX-600 spectrometer
equipped with a 5-mm x, y, z-shielded pulsed-field gradient triple-resonance probe. 2048 (1H)
× 128 (15N) complex data points were collected for each dimension. The spectral widths used
for were 8992.806 Hz for 1H and 1702.903 Hz for 15N dimensions. The data were processed
by using Felix 2002 (Felix NMR, Inc.). The final matrix contains 2048 × 2048 data points
along 1H and 15N dimensions.
MD Simulations
The designed cofactor-bound PASC was taken as the starting structure for the simulations. The
protein was solvated within a 50 × 50 × 72 Å3 water box, and periodic boundary conditions
were employed in all cell dimensions. Simulations were performed using the NAMD 2.5
package33 and the CHARMM22 all-atom force field.34 The parameratization of the six
coordinate DPP-Fe( III) macrocyle and substituents was derived from CHARM22 parameters
for the iron heme and from functional groups of amino acid side chains.34 A time step of 2 fs
was used for bonded and nonbonded interactions, and a cutoff distance of 10 Å was maintained
to calculate nonbonded interactions. Full electrostatic forces were evaluated at every other time
step through application of the particle-mesh Ewald (PME) method.35 All bonds between
hydrogen atoms and heavy atoms were constrained using the SHAKE algorithm with a
tolerance of 10−5 Å.36
Results
Design
The structure of the 108-residue single chain protein, PASC (Porphyrin Assembler, Single
Chain, Figure 1c) was designed, using the model for the corresponding homotetramer (Figure
1b, PATET) as a starting point. As described in the Methods section, interhelical loops with
favorable conformations and sequences were introduced into the structure by grafting known
interhelical backbone structures onto the PATET model. The precise conformation of the loops
in the structure were obtained by: 1) superimposing helical hairpins from proteins of known
structure onto the helices of PATET; 2) selecting hairpins with a low r.m.s.d. for the
superimposed helical residues; 3) inserting the loop at a position where the chains are
particularly well superimposed; and 4) selecting structures that did not interfere with cofactor
binding (Figure 2).30 As described in previous work,8,28 eight “keystone” residues directly
involved in cofactor ligation or second-shell interactions were predefined (four histidines and
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four threonines, Figure 3), while the remaining positions of the protein were specified using
the computational methodology SCADS (Figure 1d). The resulting protein, PASC, exhibits
complementary, asymmetric hydrophobic interactions within the interior that are difficult to
realize in symmetric bundles (Figure 4). PASC was expressed from a synthetic gene (10 – 15
mg/L pure protein) in E. coli.
UV-visible and CD spectroscopy
UV-visible spectroscopy demonstrated that PASC selectively binds FeDPP(III) in the intended
stoichiometry (2:1). Addition of protein to two equivalents of FeDPP(III) resulted in a
sharpening of the Soret band and a shift from 405 to 410 nm (Figure 5). Titration of PASC with
FeDPP(III) indicates formation of a 2:1 cofactor to protein complex (Figure S2). Reduction of
the PASC/FeDPP(III) complex with sodium dithionite resulted in a ferrous complex with
spectral signatures typical of a bis-His ligated complex (λmax = 525 nm).6,37 The Soret peak
for PASC is at 410 nm, and shifts to 419 nm when reduced with solid sodium dithionite. For
comparison, PATET showed a Soret peak at 408 nm, which shifts to 417 nm when reduced.8
The PASC/FeDPP(III) complex gives an extinction coefficient of 177,000 M−1 cm−1, whereas
the PATET complex gives an extinction coefficient of 160,000 M−1 cm−1, which are the same
within the experimental error of the protein concentration determination.
Furthermore, the visible CD spectrum showed that each cofactor was bound in a unique chiral
environment in PASC.19 The UV-visible CD spectrum of the reduced species shows that both
cofactors have been incorporated into the protein, with a change in the transition at 419 nm,
consistent with the location of the peak of the ferrous species (Figure 6a). In order to evaluate
the second binding site, the spectrum of one equivalent each of protein and cofactor was
subtracted from the spectrum of one equivalent protein and two equivalents of cofactor (Figure
6b). This revealed that there is little difference in cofactor ligation at each site, because both
sites produce a signal that is similar in magnitude and shape.
Size exclusion chromatograph and analytical ultracentrifugation (AUC) of PASC/FeDPP(III)
The association of PASC was examined by size exclusion chromatography, using a Superdex
75 analytical column (Figure 7). In the absence of cofactor, the protein elutes in a symmetrical
peak. Upon addition of one or two equivalents of FeDPP(III) per mole of PASC, the protein
eluted at a smaller volume consistent with the compaction of the structure upon association
with the cofactor. A second minor peak is also observed, and is indicative of aggregation in
the reconstitution assay. This peak can be minimized by reconstituting at a high dilution and
annealing the sample at 70 °C. Once purified, the monomeric form is stable at millimolar
concentrations for several weeks at room temperature. The monomeric peak, representing the
PASC /FeDPP(III) complex, was further examined by AUC. Analytical ultracentrifugation of
the PASC/FeDPP(III) complex revealed that it sedimented as a single molecular species with
molecular weight of 14,150 D, in excellent agreement with that for the monomeric complex,
13,932 D (Figure S1).
Far UV-CD and NMR investigation of backbone conformation of PASC
Far UV circular dichroism spectroscopy was used to examine the helical structure, stability,
and the effects of porphyrin binding in the protein as well as in PATET. The spectra of both
apo-PASC and apo-PATET were nearly identical at room temperature (Figure 8a and 8b). The
mean residue ellipticity for apo-PATET ([θ]222nm, 25°C) is reported to be −8,300 deg cm2
dmol−1. Apo-PASC is slightly less helical ([θ]222nm, 25°C = −7,200 deg cm2 dmol−1) due to the
inclusion of the loop, and also disorder near the N- and C-terminus of PASC. This trend is also
observed for the holo-scaffolds; both show an increase in helical content upon addition of the
cofactor and PASC remains less helical than PATET (Table 1).
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However, PASC demonstrated higher stability than PATET, in both the apo- and holo-forms of
the protein (Figure 8c). The addition of porphyrin resulted in a very large increase in the stability
of PASC (Tm of the apo- and holo-protein were 22 °C and 68 °C, respectively, Table 1) and
the steepness of the transition. Comparatively, the melting midpoints were determined to be 4
°C for apo-PATET and 56 °C for holo-PATET. This demonstrates the increased stability of the
scaffold PASC, due to inclusion of inter-helical links as well as better interior packing. Given
the increased stability and the fact that the scaffold demonstrated its designed behavior, it was
important to establish whether or not the scaffold was a good structural candidate by evaluating
the complex using NMR.
The NMR spectrum of PASC should provide valuable information concerning the degree to
which the protein is uniquely folded, versus adopting a molten maquette-like conformation.
Figure 9a shows that the 15N proton HSQC spectrum of PASC with FeDPP(III) at pH 7.5 is
indeed well dispersed, with approximately 70 resonances observed. The amide backbone
resonances are spread over 7 – 11 ppm in the proton dimension and 110 – 132 ppm in the 15N
dimension, indicative of a well defined, presumably uniquely folded structure. At pH 6.0, where
the exchange with solvent is slower, we expect to observe more resonances that are better
resolved (Figure 9b). The approximately 95 resonances are observed at pH 6.0 and they are
dispersed over 6 – 11 ppm in the proton dimension, 108 – 134 ppm in the 15N dimension,
consistent with a natively folded structure.
Molecular Dynamics
Molecular dynamics (MD) calculations were performed to validate the retention of key design
elements during an all-atom simulation of the molecular structure. If the sequence is well suited
to stabilize the starting three-dimensional model, the structure should equilibrate rapidly and
then show only small local deviations from its equilibrium position. However, starting
structures that are either unstable, far from their energy minimum, or dynamically averaging
on the nanosecond time scale might be expected to continuously drift from their starting
configuration during MD simulations.38 The motions of PASC in a 50 × 50 × 72 Å3 periodic
box of water were simulated for 7 ns. A plot of the RMSD of the observed structure (relative
to the starting model) versus time shows the wild type protein with FeDPP(III) equilibrates
within 200 ps, and then remains essentially constant over the remaining 7 ns (Figure 10a).
Examination of the contributions of the individual helices to the RMSD fluctuations showed
that the first and fourth helices were most variable, due to fraying of their N-terminal and C-
terminal sequences (Figure S4).
To determine the significance of the observed structural conservation of the structure over this
time scale, we introduced four mutations at positions i+4 from the His ligand. Previous work
from the groups of Suslick and Benson13–16 had shown that hydrophobic residues at these
positions contribute significantly to the stability of heme-peptide complexes. Thus, Y27, M53,
Y80, and L06 were mutated to alanine in a protein designated PASC-ALA, and the dynamics
of this protein were simulated for 7 ns. Similar to the trajectory for PASC, PASC-ALA showed
a rapid equilibration in approximately 200 ps, but then its structure continued to vary over the
remainder of the simulation, never reaching a stable configuration (Figure 10c). This finding
is reflected not only in the plots of RMSD versus time but also from an examination of the
distance between the metal ions in the two cofactors, which were essentially constant for
PASC but became continuously smaller for PASC-ALA (Figure 10b and 10d). The
computationally designed loops were also examined for stability, on the 7 ns timescale, and in
PASC both the short as well as the long inter-helical loops were highly stable on the ns time
scale (Table S1). Within the time of the simulation the phi and psi angles of the wild type
residues remained in the same basins of the Ramachandran plot (Table S1).
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Conclusion
Here we demonstrate that modern methods of computational protein design were successfully
used to yield a fully asymmetric protein that holds considerable promise for structural
characterization as well as functional studies. Specifically, this genetically expressed scaffold
allows for the facile incorporation of isotopic labels such as 15N and 13C necessary for
multidimensional NMR experiments. Structural studies to understand the nature of the binding
are underway, and are made possible by not only the successful incorporation of the non-
biological cofactor, but also by the stability of PASC in solution. The selectivity of PASC for
FeDPP(III) demonstrates the specificity of binding for a given cofactor. The design and
incorporation of additional cofactors with various functionalities is now possible and such
designs are currently underway. In conclusion, de novo protein design is a promising and
expanding approach to examine the delicate interplay between a cofactor’s environment and
its functional properties.
Supplementary Material
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Figure 1.
Model and sequence of Porphyrin Assemblers. (a) Iron diphenylporphyrin cofactor (b) Model
of PATET 8 (c) Model of PASC (d) Sequences of PATET and PASC, which have the helical
regions underlined, and the heptad positions of the residues are lettered. Keystone residues are
bolded.
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Figure 2.
Model of loop choices for PASC. Each color corresponds to a section from the structures
selected from the PDB: 2spc (light pink), lim8 (red), 1t06 (blue), 1fzn (magenta), 1g03
(orange), and lea3 (light green). The loop 1t06 (in blue) had the lowest deviation in RMSD
from the PATET helices (shown in gray, they correspond to Helix 2 and 3 of PASC), and was
chosen for the PASC scaffold.
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Figure 3.
Keystone residues in PASC. Histidines are shown in blue, Threonines are shown in pink, and
the porphyrin ring of FeDPP(III) is shown in yellow; hydrogen bonds are shown as dotted lines
from the Fe to N(ε) of His, and from the Thr O(γ) to N(δ) of His.
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Figure 4.
The asymmetric hydrophobic interior of PASC. Dark Blue = His, Yellow = Met and Phe, Red
= Ala; blue ribbon section are the Histidines. The non-symmetric hydrophobic core of PASC
consists of residues A16, M20, F42, M46, F69, M73, A95, and M99. These residues were
picked by SCADS as residues dominating the probability profiles at their respective positions.
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Figure 5.
Cofactor binding selectivity. (a) PASC demonstrates cofactor selectivity for FeDPP(III) over
a biological cofactor, (b) iron protoporphyrin IX, FePPIX(III). Cofactor was added to the
protein in 50 mM phosphate buffer, 100 mM NaCl, pH 7.5 as described in the methods.
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Figure 6.
Circular Dichroism spectroscopy in the visible-UV region. (a) The addition of sub-
stoichiometric (25 µM) and stoichiometric (50 µM) amounts of FeDPP(II) to 25 µM PASC at
25 °C in 10 mM phosphate buffer at pH 7.5. (b) The spectra demonstrate equality of binding
sites within the PASC scaffold.
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Figure 7.
Size Exclusion Chromatography of the PASC apo- and holo-complexes. The apo-protein eluted
at a higher retention time (11 mL, black line) than the holo-protein (12.3 mL, dotted line),
indicating that once the cofactor binds, the holo-protein is more compact.
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Figure 8.
Circular Dichroism spectroscopy in the near-UV region. (a) The spectra of apo-PASC (25 µM
protein, shown in circles) and holo-PASC (25 µM protein + 50 µM FeDPP(III), shown in
squares) at 25°C demonstrate the increase in helicity upon addition of FeDPP(III). (b) Spectra
of apo-PATET (50 µM protein, shown in triangles) and holo-PATET (50 µM protein + 25 µM
FeDPP(III), shown in diamonds). (c) Fraction folded for PATET (apo, holo) and PASC (apo,
holo) demonstrate that the Tm’s (°C) for PASC are higher than those for PATET, indicating
increased stability.
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Figure 9.
Heteronuclear Single Quantum Correlation NMR of PASC (a) The 1H-15N HSQC spectrum of
0.83 mM PASC and 1.6 mM FeDPP(III) in 50 mM phosphate buffer, 200 mM NaCl, pH 7.5,
at 45 °C. (b) The 1H-15N HSQC spectrum of 1.1 mM PASC and 2.2 mM FeDPP(III) in 100
mM phosphate buffer, 150 mM NaCl, pH 6.0, at 45 °C.
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Figure 10.
Molecular Dynamics simulations. Comparison of trajectories of the backbone RMSD and the
metal-to-metal distance versus time for the PASC scaffold. The wild type system (PASC +
FeDPP(III)) backbone RMSD is shown in (a), whereas the mutant (PASC-ALA + FeDPP(III))
backbone RMSD is in (c). The metal-to-metal distances for the wild type system (b) are shown
in contrast to that for the mutant system (d).
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Table 1
Summary of CD data for PATET and PASC, both apo- and holo-proteins.
[θ222 nm] 0°C[a] Tm[b] Concentration[c]
PATET (holo) 
[d] −23,800 56 50
PATET (apo) −4,200 4 50
PASC (holo) 
[e] −14,500 68 25
PASC (apo) −3,900 22 25
[a]




Concentration of protein scaffold (µM)
[d]
25 µM FeDPP added to scaffold PATET
[e]
50 µM FeDPP added to scaffold PASC
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